Skip to main content
. 2019 Jun 17;2019(6):CD002253. doi: 10.1002/14651858.CD002253.pub4

Nielsen 1999.

Methods Randomisation method not discussed in paper.
Sahlgrenska University Hospital, Sweden. No information on study duration.
Participants 122 women < 13 weeks with symptoms of threatened miscarriage (bleeding +/‐ pain), a closed cervix, and ultrasound demonstration of pregnancy non‐viability (anembryonic pregnancy n = 44; embryonic/fetal death n = 46; 'complex mass with deformed gestational sac' n = 32). Surgical evacuation at day 5 if transvaginal ultrasound showed retained products > 15 mm diameter.
Interventions Mifepristone (400 mg orally) followed by oral misoprostol (400 mcg) 48 hours later (n = 60) vs expectant management (n = 62).
Outcomes Clinical events; routine transvaginal ultrasound at 5 days to identify retained products; visual analogue scale to assess pain at day 5; visual analogue scale to assess satisfaction at day 14.
Funding No information on funding.
Declarations of interest No information on conflicts of interest.
Notes Seeking clarification from authors if "complex mass with deformed gestational sac" represents missed or incomplete miscarriage. Data included in meantime.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Comment: randomisation method not discussed in paper.
Allocation concealment (selection bias) Unclear risk Comment: no information on allocation concealment.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Comment: no loss to follow‐up, no signs of missing data.
Selective reporting (reporting bias) Low risk Comment: no signs of selective reporting.
Other bias Low risk No other source of bias could be detected
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Comment: article does not state that in the expectant management group placebo were used. Therefore there probably was no blinding of participants and personnel.
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Comment: no information on blinding of outcome assessment, probably not done.